Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

One-year serum albumin is an independent predictor of outcomes in kidney transplant recipients.

Dahlberg R, Muth B, Samaniego M, Hofmann RM, Pirsch J, Djamali A.

J Ren Nutr. 2010 Nov;20(6):392-7. doi: 10.1053/j.jrn.2010.03.008. Epub 2010 May 26.

2.

Prognostic Significance of 1-Year Serum Albumin Levels Within the Normal Range After Kidney Transplantation.

Oh IH, Park JS, Lee CH, Kang CM, Kim GH.

Artif Organs. 2015 Nov;39(11):965-72. doi: 10.1111/aor.12473. Epub 2015 Apr 20.

PMID:
25894393
3.

Risk Factors Affecting Graft and Patient Survivals After Transplantation From Deceased Donors in a Developing Country: A Single-Center Experience.

Ayar Y, Ersoy A, Ocakoglu G, Yildiz A, Oruc A, Soyak H, Calapkulu M, Sahin AB, Topal NB, Okeer E, Coskun B, Kaygisiz O, Kordan Y, Vuruskan H.

Transplant Proc. 2017 Mar;49(2):270-277. doi: 10.1016/j.transproceed.2016.12.009.

PMID:
28219583
4.

Associations of pretransplant serum albumin with post-transplant outcomes in kidney transplant recipients.

Molnar MZ, Kovesdy CP, Bunnapradist S, Streja E, Mehrotra R, Krishnan M, Nissenson AR, Kalantar-Zadeh K.

Am J Transplant. 2011 May;11(5):1006-15. doi: 10.1111/j.1600-6143.2011.03480.x. Epub 2011 Mar 30.

5.

Morbid obesity is not an independent predictor of graft failure or patient mortality after kidney transplantation.

Pieloch D, Dombrovskiy V, Osband AJ, Lebowitz J, Laskow DA.

J Ren Nutr. 2014 Jan;24(1):50-7. doi: 10.1053/j.jrn.2013.07.001. Epub 2013 Sep 23.

PMID:
24070588
6.

Recipient-related risk factors for graft failure and death in elderly kidney transplant recipients.

Lai X, Chen G, Qiu J, Wang C, Chen L.

PLoS One. 2014 Nov 12;9(11):e112938. doi: 10.1371/journal.pone.0112938. eCollection 2014.

7.

Long-term improvement of deceased donor renal allograft survival since 1996: a single transplant center study.

Sola E, Gonzalez-Molina M, Cabello M, Burgos D, Ramos J, Gutierrez C, Lopez V, Soler J, de la Vega E, Hernandez D.

Transplantation. 2010 Mar 27;89(6):714-20. doi: 10.1097/TP.0b013e3181c892dd.

PMID:
20035250
8.

Advantages of kidney transplant precocity in graft long-term survival.

Malho A, Malheiro J, Fonseca I, Martins LS, Pedroso S, Almeida M, Dias L, Castro Henriques A, Cabrita A.

Transplant Proc. 2012 Oct;44(8):2344-7. doi: 10.1016/j.transproceed.2012.07.030.

PMID:
23026589
9.

Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.

Heinze G, Mitterbauer C, Regele H, Kramar R, Winkelmayer WC, Curhan GC, Oberbauer R.

J Am Soc Nephrol. 2006 Mar;17(3):889-99. Epub 2006 Feb 15.

10.

Clinical outcomes in elderly kidney transplant recipients are related to acute rejection episodes rather than pretransplant comorbidity.

Heldal K, Hartmann A, Leivestad T, Svendsen MV, Foss A, Lien B, Midtvedt K.

Transplantation. 2009 Apr 15;87(7):1045-51. doi: 10.1097/TP.0b013e31819cdddd.

PMID:
19352126
11.

Renin-angiotensin system blockade and kidney transplantation: a longitudinal cohort study.

Hernández D, Muriel A, Abraira V, Pérez G, Porrini E, Marrero D, Zamora J, González-Posada JM, Delgado P, Rufino M, Torres A.

Nephrol Dial Transplant. 2012 Jan;27(1):417-22. doi: 10.1093/ndt/gfr276. Epub 2011 May 28.

PMID:
21622985
12.

Hypertension, antihypertensive agents and outcomes following renal transplantation.

Tutone VK, Mark PB, Stewart GA, Tan CC, Rodger RS, Geddes CC, Jardine AG.

Clin Transplant. 2005 Apr;19(2):181-92.

PMID:
15740553
13.

Donor-recipient age difference and graft survival in living donor kidney transplantation.

Lee YJ, Chang JH, Choi HN, Jung JY, Kim YS, Chung WK, Park YH, Lee HH.

Transplant Proc. 2012 Jan;44(1):270-2. doi: 10.1016/j.transproceed.2011.12.013.

PMID:
22310630
14.

Influence of Factors Associated With the Deceased-Donor on Kidney Transplant Outcomes.

Stolyar AG, Budkar LN, Solodushkin SI, Iumanova IF.

Exp Clin Transplant. 2015 Oct;13(5):394-401.

15.

Risk variables associated with the outcome of kidney recipients >70 years of age in the new millennium.

Heldal K, Hartmann A, Leivestad T, Foss A, Midtvedt K.

Nephrol Dial Transplant. 2011 Aug;26(8):2706-11. doi: 10.1093/ndt/gfq786. Epub 2011 Feb 1.

PMID:
21285131
16.

Fetuin-A pretransplant serum levels, kidney allograft function and rejection episodes: a 3-year posttransplantation follow-up.

Roos M, Heinemann FM, Lindemann M, Horn PA, Lutz J, Stock K, Thürmel K, Baumann M, Witzke O, Heemann U.

Kidney Blood Press Res. 2011;34(5):328-33. doi: 10.1159/000327848. Epub 2011 May 26.

17.

Short-term and long-term survival of kidney allograft: cure model analysis.

Mirzaee M, Azmandian J, Zeraati H, Mahmoodi M, Mohammad K, Etminan A, Dehghani Firouzabadi MH, Habibzade S, Haghparast M.

Iran J Kidney Dis. 2014 May;8(3):225-30.

18.

Low testosterone at time of transplantation is independently associated with poor patient and graft survival in male renal transplant recipients.

Shoskes DA, Kerr H, Askar M, Goldfarb DA, Schold J.

J Urol. 2014 Oct;192(4):1168-71. doi: 10.1016/j.juro.2014.03.102. Epub 2014 Apr 1.

PMID:
24704018
19.

Very early serum creatinine as a surrogate marker for graft survival beyond 10 years.

Pascual J, Marcén R, Zamora J, Fernández AM, Burgos FJ, Villafruela JJ, Ortuño J.

J Nephrol. 2009 Jan-Feb;22(1):90-8.

PMID:
19229823
20.

Association between a change in donor kidney function and long-term allograft outcomes in kidney transplant recipients.

Oh IH, Lee CH, Kim GH, Kang CM, Park JS.

Artif Organs. 2015 Mar;39(3):254-9. doi: 10.1111/aor.12367. Epub 2014 Sep 10.

PMID:
25205383

Supplemental Content

Support Center